Antiviral Therapy
Antiviral Therapy is an international, peer-reviewed, open access journal devoted to publishing articles on the clinical development and use of antiviral agents and vaccines, and the treatment of all viral diseases. Antiviral Therapy is one of the leading journals in virology and infectious diseases.
The journal is comprehensive, and publishes articles concerning all clinical aspects of antiviral therapy. It features editorials, original research papers, specially commissioned review articles, letters and book reviews. The journal is aimed at physicians and specialists interested in clinical and basic research.
Antiviral Therapy is abstracted by Index Medicus/MEDLINE, Current Contents/Clinical Medicine, EMBASE/Exerpta Medica, SciSearch, Research Alert and Chemical Abstracts.
Open access article processing charge (APC) information
Publication in the journal is subject to payment of an article processing charge (APC). The APC serves to support the journal and ensures that articles are freely accessible online in perpetuity under a Creative Commons licences.
The APC for this journal is currently an introductory rate of $1,400, discounted from the full rate of $2,800. The introductory rate is available for a limited time.
The APC is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.
Submit your manuscript today at https://mc.manuscriptcentral.com/avt
This journal changed its publication mode from subscription to open access in January 2022. Content from 1999-2022 is hosted free-access. Please see this page for information on reuse rights of archival material.
Antiviral Therapy is an international, peer-reviewed journal devoted to publishing articles on the clinical development and use of antiviral agents and vaccines, and the treatment of all viral diseases. Antiviral Therapy is one of the leading journals in virology and infectious diseases. It publishes original scientific papers in all therapeutic areas including:
- Results of clinical studies in all phases
- Viral diagnostics and individualization of antiviral therapy
- Study design issues in the clinical assessment of antivirals
- Antiviral drug safety and safety monitoring
- Mechanisms of resistance to antiviral agents
- Pharmacoepidemiology of viral diseases
Antiviral Therapy also features review articles, editorials, book reviews and a letters section to provide a forum for discussion.
| Douglas D. Richman | University of California, San Diego, USA |
| Katharine J. Bar | University of Pennsylvania, Philadelphia, USA |
| Peter Reiss | University of Amsterdam, the Netherlands |
| Daniel Streblow | University of Wisconsin, Madison, USA |
| Barbara Testoni | French Institute of Health and Medical Research, Paris, France |
| Richard J. Whitley | The University of Alabama at Birmingham, USA |
| Amalio Telenti | University of California, San Diego, USA |
| Mariana Baz | Université Laval, Quebec, Canada |
| Andrés Pizzorno | International Center for Research in Infectious Diseases, Lyon, France |
| Elaine J. Abrams | Columbia University, New York, USA |
| Tanya Lynn Applegate | UNSW College, Kensington, Australia |
| John R. Arribas | Hospital Universitario La Paz, Madrid, Spain |
| Mariana Baz | Université Laval, Quebec, Canada |
| Georg Behrens | Hannover Medical School, Hannover, Germany |
| Karen K. Biron | Clinical Virology, GlaxoSmithKline, Research Triangle Park, USA |
| Marta Boffito | Imperial College, London, UK |
| Guy Boivin | Université Laval, Quebec, Canada |
| Anders Boyd | University of Amsterdam, the Netherlands |
| David M. Burger | Radboud University Medical Center, Nijmegen, the Netherlands |
| Jacqueline Capeau | French Institute of Health and Medical Research, Paris, France |
| Kara Carter | Evotec, Boston, USA |
| Ann Collier | University of Washington, Seattle, USA |
| Janet Englund | University of Washington, Seattle, USA |
| Michael Gale | University of Washington, Seattle, USA |
| Lutz Gissmann | German Cancer Research Center, Heidelberg, Germany |
| Peter Hunt | University of California, San Francisco, USA |
| Aeron Hurt | WHO Collaborating Centre for Reference and Research on Influenza in Melbourne, Australia |
| Michael Ison | Northwestern University Feinberg School of Medicine, Chicago, USA |
| Scott James | The University of Alabama at Birmingham, USA |
| Ji-Dong Jia | Liver Research Centre at the Beijing Friendship Hospital, Capital University in Beijing, China |
| Christine Johnson | Department of Medicine at University of Washington, Seattle, USA |
| Yun-Fan Liaw | Chang Gung University College of Medicine, Taipei, Taiwan |
| Hermione Lyall | Imperial College Healthcare NHS Trust, London, UK |
| Gary Maartens | University of Cape Town, South Africa |
| Patrick Marcellin | Hôpital Beaujon, Clichy, France |
| Catia Marzolini | University Hospital of Basel, Switzerland |
| Gail V. Matthews | University of New South Wales, Kensington, Australia |
| Luis Menéndez-Arias | Autonomous University of Madrid, Spain |
| Jean-Michel Molina | University of Paris, France |
| David Mutimer | University of Birmingham, UK |
| Johan Neyts | University of Leuven (KU Leuven), Belgium |
| Ighovwerha Ofotokun | Emory University School of Medicine, Atlanta, USA |
| Andri Rauch | University of Bern, Switzerland |
| Carlos del Rio | Emory University School of Medicine, Atlanta, USA |
| Juergen Rockstroh | University of Bonn, Germany |
| Caroline Sabin | University College London, UK |
| Jonathan Schapiro | National Hemophilia Center, Sheba Medical Center, Ramat Gan, Israel |
| Adam Trickey | University of Bristol, UK |
| Francois Venter | Ezintsha, University of the Witwatersrand, Johannesburg, South Africa |
| Laura Jane Waters | Mortimer Market Centre, London, UK |
| Vincent Wai-Sun Wong | The Chinese University of Hong Kong, Hong Kong |
Manuscript submission guidelines can be accessed on Sage Journals.